TNF and COVID-19: This publication serves as a strong reminder for clinicians involved in the management of COVID-19 to consider Strongyloides hyperinfection in patients with COVID-19 who demonstrate little or no improvement after receiving medications associated with immunosuppression, especially corticosteroids and tumor necrosis factor inhibitors.